EUVIMEDEUVIMED entdecken
Leitlinie

Complex Lymphatic Anomalies: Report on a Patient Registry Using the Latest Diagnostic Guidelines

Themis-Areti A Andreoti, Sebastian Berg, Annegret Holm, Marina Angerer, Michael Oberlin, Etelka Foeldi, Iris Baumgartner, Charlotte M Niemeyer, Jochen Rössler iD, Friedrich G Kapp

Lymphatic Research and Biology · 01.06.2023 · 21 (3) · 230-243

DOI: 10.1089/lrb.2022.0041 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Lymphatic Research and Biology, online erschienen am 23.06.2023. Verfasst von Themis-Areti A Andreoti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology and Oncology, Department of Pediatrics, Inselspital-University Hospital of Bern, University of Bern, Bern, Switzerla…. Hauptthemen laut MEDLINE: Lymphatic Abnormalities, Osteolysis, Essential, Lymphatic Vessels. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Generalized lymphatic anomaly (GLA), Gorham-Stout disease (GSD), kaposiform lymphangiomatosis (KLA), and central conducting lymphatic anomaly (CCLA) are rare, multisystem lymphatic disorders, referred to as complex lymphatic anomalies (CLAs). Their etiology remains poorly understood; however, somatic activating mutations have recently been discovered, and the results of targeted treatments are promising. This study aimed to elaborate on the phenotypic description of CLA.

Methods

Thirty-six consecutive patients were recruited for the “GLA/GSD Registry” of the University Hospital of Freiburg, Germany (2015–2021). Clinical data were prospectively collected provided that a signed informed consent form was obtained. The latest proposed diagnostic guidelines were retrospectively applied.

Results

Thirty-two patients (38% males) were included in the study; 15 GLA, 10 GSD, 3 KLA, and 4 CCLA patients were identified. Eighty-four percent already had symptoms by the age of 15 years. Osteolysis and periosseous soft-tissue infiltration were associated with GSD ( p < 0.001 and p = 0.011, respectively), ascites and protein-losing enteropathy with CCLA ( p = 0.007 and p = 0.004, respectively), and consumption coagulopathy with KLA ( p = 0.006). No statistically significant differences were found in organ involvement, distribution of osteolytic lesions, number of affected bones and fractures. Twenty-five patients had complications; one patient with GLA died despite multimodal treatment. Spontaneous regression was seen in one patient with untreated KLA.

Conclusions

CLA are rare, and their overlapping clinical presentations make differential diagnosis difficult. The characterization of our case series contributes to the phenotypic description and differentiation of these four clinical entities. A further understanding of their pathogenesis is crucial for evaluating targeted therapies and optimizing medical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphatic AbnormalitiesOsteolysis, EssentialLymphatic VesselsMaleHumansAdolescentFemaleRetrospective StudiesBone and Bones

Stichwörter der Autor:innen

Gorham-Stout diseasecentral conducting lymphatic anomalycomplex lymphatic anomalygeneralized lymphatic anomalykaposiform lymphangiomatosislymphatic malformation

Autor:innen und Institutionen

  • Division of Pediatric Hematology and Oncology, Department of Pediatrics, Inselspital-University Hospital of Bern, University of Bern, Bern, Switzerland.
  • Graduate School for Health Sciences, University of Bern, Bern, Switzerland.
  • Division of Pediatric Radiology, Department of Radiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • VASCERN (European Network of rare vascular diseases) HCP (Health Care Provider) Freiburg-Hinterzarten, Germany.
  • Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Vascular Biology Program, Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Jochen Rössler

Zitieren

APA

Andreoti, T. A., Berg, S., Holm, A., Angerer, M., Oberlin, M., Foeldi, E., Baumgartner, I., Niemeyer, C. M., Rössler, J., & Kapp, F. G. (2023). Complex Lymphatic Anomalies: Report on a Patient Registry Using the Latest Diagnostic Guidelines. Lymphatic Research and Biology, 21(3), 230-243. https://doi.org/10.1089/lrb.2022.0041

Vancouver

Andreoti TA, Berg S, Holm A, Angerer M, Oberlin M, Foeldi E, et al. Complex Lymphatic Anomalies: Report on a Patient Registry Using the Latest Diagnostic Guidelines. Lymphatic Research and Biology. 2023;21(3):230-243. doi:10.1089/lrb.2022.0041

BibTeX
@article{Andreoti2023,
  author = {Andreoti, Themis-Areti A and Berg, Sebastian and Holm, Annegret and Angerer, Marina and Oberlin, Michael and Foeldi, Etelka and Baumgartner, Iris and Niemeyer, Charlotte M and Rössler, Jochen and Kapp, Friedrich G},
  title = {Complex Lymphatic Anomalies: Report on a Patient Registry Using the Latest Diagnostic Guidelines},
  journal = {Lymphatic Research and Biology},
  year = {2023},
  volume = {21},
  number = {3},
  pages = {230--243},
  doi = {10.1089/lrb.2022.0041}
}
Kostenlos starten →